Neutral impactStocks
Aequs board approves ₹650 cr equity infusion for capacity expansion
BusinessLine 17 hrs ago·26 Sept 2026, 6:30 am
Of the total issue size of approximately ₹650 crore, ₹325 crore will be payable upfront upon allotment of the warrants, representing 50% of the issue size and twice the regulatory minimum
Affected stocks
Neutral1 stock
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Aequs (AEQUS).
- Category: Stocks.
Why it matters
A routine update for Aequs. Use the price and stock snapshot to gauge how the market is responding.
